Cite
MLA Citation
Francois Curtin et al.. “A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes.” Diabetes, obesity & metabolism, vol. 22, no. 7, 2020, pp. 1111–1121. http://access.bl.uk/ark:/81055/vdc_100103798217.0x000020